Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,352 public trials 1,986 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, Not Recruiting

A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

NCT06247995

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
  • Uni Of TX MD Anderson Cancer Cntr Houston, Texas, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

NCT01901094

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Southern Cancer Center PC-Daphne Daphne, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Southern Cancer Center PC-Mobile Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
View all 1246 locations
View Trial Details
Active, Not Recruiting

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

NCT05455658

Conditions
Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, +21 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)

NCT04895358

Conditions
Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, +8 more
Locations
  • University of Alabama at Birmingham-Medicine ( Site 0065) Birmingham, Alabama, United States
  • Arizona Oncology Associates-Arizona Oncology ( Site 0049) Tucson, Arizona, United States
  • Pacific Cancer Care ( Site 0023) Monterey, California, United States
  • UCSF Medical Center at Mission Bay ( Site 0043) San Francisco, California, United States
View all 256 locations
View Trial Details
Active, Not Recruiting

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

NCT02414269

Conditions
Adenoma, Breast Cancer, Breast Diseases, +21 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and Follow-Up) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow-Up) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Consent and Follow-Up) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer

NCT05132582

Conditions
Breast Diseases, Breast Neoplasms, HER2 Positive Breast Cancer, +4 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Central Arkansas Radiation Therapy Institute Inc d.b.a CARTI Little Rock, Arkansas, United States
  • UCLA Hematology/Oncology - Beverly Hills Beverly Hills, California, United States
View all 307 locations
View Trial Details

Related conditions